Live Breaking News & Updates on Microbiota Therapeutics Program

Stay updated with breaking news from Microbiota therapeutics program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

University of Minnesota: New University of Minnesota collaboration with OpenBiome to treat patients with recurrent C. difficile infections

OpenBiome is announcing a collaboration with the University of Minnesota’s Microbiota Therapeutics Program to ensure that patients with recurrent C. difficile infections have access to fecal microbiota transplantation (FMT) until an FDA-approved alte ....

United States , Michael Sadowsky , Julie Obrien , Alexander Khoruts , University Of Minnesota Microbiota Therapeutics Program , National Registry , National Institutes Of Health , University Of Minnesota , American Gastroenterological Association , Microbiota Therapeutics Program , Good Manufacturing Practices , Achieving Cures Together , National Institutes , Julieo Brien ,

University of Minnesota and OpenBiome Agree to Treat C. difficile Infections

According to the CDC, C. difficile is a bacterium that causes severe diarrhea and colitis. It’s estimated to cause almost half a million infections in the U.S. each year. About one in six patients who get C. difficile will get it again in the subsequent 2-8 weeks. One in eleven people over age 65 diagnosed with a healthcare-associated C. difficile infection die within one month. ....

United States , Michael Sadowsky , Alexander Khoruts , University Of Minnesota Microbiota Therapeutics Program , National Registry , University Of Minnesota , American Gastroenterological Association , Microbiota Therapeutics Program , Good Manufacturing Practices , Achieving Cures Together ,